Skip to main content

Table 1 Clinical characteristics of patients

From: Efficacy and safety of self-expanding metallic stent placement followed by neoadjuvant chemotherapy and scheduled surgery for treatment of obstructing left-sided colonic cancer

Variables

n = 11

Age (y), median (range)

67 (43–72)

Male / female

7 (63.6)

BMI (kg/m2), median (range)

22.6 (20.1–26.6)

ASA score before stent placement, n (%)

 I or II

9 (81.8)

 III

2 (18.2)

Tumor location, n (%)

 Sigmoid colon

7 (63.6)

 Descending colon

2 (18.2)

 Splenic flexure of colon

2 (18.2)

Smoking, n (%)

4 (36.4)

Alcohol consumption, n (%)

4 (36.4)

COPD, n (%)

1 (9.1)

Diabetes mellitus, n (%)

3 (14.3)

Hypertension, n (%)

5 (23.8)

Albumin (g/L), median (range)

33.3 (28.9–35.3)

Hemoglobin (g/L), median (range)

93.0 (70.0–144.0)

Prealbumin (g/L), median (range)

0.16 (0.12–0.22)

Bowel wall thickness at the beginning of the study (mm), median (range)

3.8 (3.0–7.0)

Preoperative chemotherapy regimen

 CAPOX

6 (54.5)

 mFOLFOX6

5 (45.5)

ypT, n (%)

 T3

9 (81.8)

 T4

2 (18.2)

ypN, n (%)

 N0

6 (54.5)

 N1

4 (36.4)

 N2

1 (9.1)

Tumor regression gradea

 1

4 (36.4)

 2

5 (45.5)

 3

2 (18.2)

 Perineural invasion

0

 Lymphvascular invasion

2 (18.2)

 Tumor deposits

1 (9.1)

 The time interval to elective operation (d), median (range)

69 (62–75)

 Follow-up

44 (37–55)

  1. BMI Body mass index, ASA American Society of Anesthesiologists, COPD chronic obstructive pulmonary disease, CRM circumferential resection margin
  2. aModified Dworak tumor regression grade system